EATG » R&D

R&D

AIDS conference: Will the UN High-Level Panel report deliver R&D and access to medicines?

DURBAN, South Africa, July 20 – The lessons derived from the history of AIDS treatment have become a rallying call for civil society organisations globally. Not being able to afford…

Early collaboration – a recipe for solutions: drug development and treatment strategies may go hand in hand

Join this webinar held as part of EUPATI, a key project co-led by EATG How early in the development of a new medicine should the discussion between researchers and patients…

Panels brainstorm ideas on innovation and drug access

The quest of balance between encouraging medical innovation and the imperative of broad access to medicines has so far been elusive. Two Harvard University programmes jointly organised a workshop this…

Alcohol, not marijuana, linked to liver injury in women with both HIV and hepatitis C

Hepatitis C virus (HCV) infects the liver and can cause inflammation. If the infection becomes chronic, the struggle between the virus and the immune system results in healthy liver tissue…

WHO takes first step towards de-linking drug prices from access and innovation issues

The World Health Organisation (WHO) will establish an expert technical committee that will help countries set health priorities as well as a global observatory that identifies gaps in health research…

1 3 4 5